Genetic variants of the IgA Fc receptor (FcαR, CD89) promoter in chronic hepatitis C patients
Authors:
- 11 October 2006
- journal article
- research article
- Published by Springer Nature in Immunogenetics
- Vol. 58 (12) , 937-946
Abstract
Fc receptor for IgA (FcαR, CD89) is capable of triggering IgA-mediated immune responses to pathogens and has been proposed to function in circulating IgA clearance. Because inheritable variations modifying individual immune responses or immunoglobulin catabolism may affect the chronicity of viral infection, we investigated whether promoter polymorphisms of the FcαR gene (FCAR) affect chronic hepatitis C virus (HCV) infection and its disease progression. The two −311T/C and −142T/C single-nucleotide polymorphisms (SNPs) were studied by direct DNA sequencing in 177 Japanese patients with chronic hepatitis C (CHC). Both −311CC and −142CC genotypes were more frequent in CHC patients (15.9 and 18.6%) compared with 210 healthy controls (5.7 and 10.0%) [p = 0.001, odds ratio (OR) = 3.10, 95% confidence interval CI) = 1.53–6.30 and p = 0.014, OR = 2.06, 95% CI = 1.14–3.72, respectively], and were associated with infection with HCV genotype 2a/2b (p = 0.019 and p = 0.005, respectively). Conversely, −311CC and −142CC were decreased in 59 patients at advanced stages of disease as assessed on the basis of hepatic fibrosis markers such as decreased platelet count (PLT) ( < 150,000/μl) (5.1 and 8.5%) compared with 91 patients with normal PLT ( ≥ 150,000/μl) (24.2 and 26.4%) (p = 0.006 and p = 0.005, respectively). Moreover, among the patients with normal PLT (but not with decreased PLT), −311CC or −142CC was significantly associated with decreased serum IgA levels (p = 0.023 or p = 0.007, respectively). These results suggest that the FCAR promoter SNPs may be related to chronic HCV infection and disease progression in Japanese CHC, which might be explained by altered FcαR expression affecting IgA-mediated immune responses and/or IgA catabolism.Keywords
This publication has 56 references indexed in Scilit:
- C/EBPα functionally and physically interacts with GABP to activate the human myeloid IgA Fc receptor (FcαR, CD89) gene promoterBlood, 2005
- Interaction of immune complexes isolated from hepatitis C virus-infected individuals with human cell linesMedical Microbiology and Immunology, 2004
- Alternative splicing of myeloid IgA Fc receptor (FcαR, CD89) transcripts in inflammatory responsesFEBS Letters, 2003
- Polymorphism in promoter region of Fcα receptor gene in patients with IgA nephropathyHuman Genetics, 2001
- Significance of IgM anti-HCVcore level in chronic hepatitis CJournal of Hepatology, 1997
- Impaired Fcα receptor expression is linked to increased immunoglobulin A levels and disease progression in HIV-1-infected patientsAIDS, 1995
- Clinical study of IgA antibody against hepatitis C virus core antigen in patients with type C chronic liver diseaseDigestive Diseases and Sciences, 1995
- IgM and IgA antibodies generated against hepatitis C virus core antigen in patients with acute and chronic HCV infectionDigestive Diseases and Sciences, 1994
- Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis CJournal of Hepatology, 1994
- Detection of Replicative Form of Hepatitis C Virus RNA in Peripheral Blood Mononuclear CellsThe Journal of Infectious Diseases, 1992